Parallax Volatility Advisers, L.P. Acelrx Pharmaceuticals Inc Call Options Transaction History

Parallax Volatility Advisers, L.P.

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q1 2019 May 15, 2019	SELL	$2.35 - $3.83 $470,000 - $766,000	-200,000 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$2.13 - $4.8 $426,000 - $960,000	200,000 New	200,000 $462,000

Ticker ACRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 7,366,600
Market Cap $8.32M
Description
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.